Fortress Biotech Inc.

NASDAQ: FBIO · Real-Time Price · USD
2.13
0.17 (8.67%)
At close: Aug 15, 2025, 3:59 PM
2.17
1.88%
After-hours: Aug 15, 2025, 07:26 PM EDT

Fortress Biotech Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-74.82M -89.15M -72.12M -69.97M -118.33M -134.45M -182.62M -224.95M -219.58M -213.91M -224.98M -217.78M -188.24M -164.83M -116.81M -100.91M -104.98M
Depreciation & Amortization
-1.28M -1.77M 1.18M 6.84M 6.83M 7.55M 8.43M 8.03M 9.07M 9.35M 8.44M 7.83M 7.38M 6.79M 6.48M 6.08M 5.64M
Stock-Based Compensation
21.19M 26.05M 13.56M 17.94M 17.16M 17.03M 18.83M 21.29M 22.16M 22.99M 24.52M 22.01M 21.28M 19.49M 15.58M 14.43M 13.82M
Other Working Capital
-1.75M -3.64M -3.5M -4.97M -6.55M -4.64M -4.26M -4.86M -5.79M -5.43M -4.71M -5.65M -6.55M 756K -778K 1.42M 4.37M
Other Non-Cash Items
-8.48M -7.19M -3.45M -3.96M 12.75M 9.96M 2.52M 3.32M 1.51M 2.89M 6.9M 13.22M 24.3M 24.43M 21M 18.37M 9.34M
Deferred Income Tax
n/a n/a -20.85M -25.84M -15.79M -15.79M 5.05M 10.05M n/a n/a 378K -11.75M -32.96M -38.8M -45.02M -32.69M -11.06M
Change in Working Capital
-13.79M -8.13M -20.55M -23.94M -13M -12.52M 6.65M 14.64M 11.09M -715K 14.49M 37.79M 26.53M 36.37M 20.43M -5.8M 3.77M
Operating Cash Flow
-74.37M -80.19M -102.22M -98.94M -110.39M -128.22M -141.13M -167.63M -175.76M -179.4M -170.25M -148.68M -141.71M -116.54M -98.33M -100.53M -83.48M
Capital Expenditures
n/a n/a -63K -1.06M -1.1M -1.1M -1.43M -1.45M -1.72M -3.06M -6.17M -12.69M -17.23M -16.35M -14.41M -9.62M -5.85M
Cash Acquisitions
n/a n/a n/a n/a 5M -5K 20M -5K 15M 20M n/a 20M n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-13.84M -15M -35K 4.96M -2.04M -2.04M -22M -6.87M -19.87M -39.87M 35.44M 8.23M 25.08M 45.08M -11.1M -7.3M -3.99M
Investing Cash Flow
-13.84M -15M -63K 4.94M 2.9M -2.1M -2.43M -8.32M -6.59M -22.93M 30.82M 24.17M 19.64M 40.51M -14.41M -9.62M -5.85M
Debt Repayment
-7.96M -7.33M 2.29M 9.62M -38.85M -38.79M -50.47M -35.47M 7.98M 49.25M 35.85M 28.35M 28.37M -12.95M -2.56M -1.38M -1.38M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a -371K -371K -371K -371K n/a n/a n/a n/a
Dividend Paid
-2.69M -4.71M -6.73M -8.75M -8.76M -8.77M -8.77M -8.78M -8.78M -8.78M -8.78M -8.78M -8.59M -8.59M -8.59M -8.17M -7.74M
Other Financial Acitivies
46.38M -163K 533K -196K 19.63M 14.87M 12.6M 12.86M -2.42M 10.12M 17.17M 17.63M 16.54M 797K -6.22M -43.16M -42.09M
Financial Cash Flow
94.92M 70.64M 88.45M 83.06M 38.41M 32.74M 7.74M 14.17M 47.54M 75.32M 95.64M 98.86M 120.27M 148.99M 147.07M 186.93M 228.35M
Net Cash Flow
6.72M -24.55M -16.27M -13.38M -71.52M -100.03M -135.83M -161.78M -134.81M -127.01M -43.8M -25.65M -1.81M 72.97M 34.33M 76.78M 139.03M
Free Cash Flow
-89.37M -95.19M -102.28M -100M -111.49M -129.32M -142.56M -169.07M -177.48M -182.46M -176.42M -161.37M -158.94M -132.89M -112.74M -110.15M -89.32M